chemotherapy undergone radiation treatment doubled survival rate group patients common type inoperable lung cancer according national study released today new england journal medicine of patients underwent radiation therapy 11 survived three years treatment contrasted 23 underwent five weeks chemotherapy followed six weeks daily radiation therapy according lead author study dr robert o dillman medical director hoag cancer center newport beach the good news adding little bit chemotherapy doubling survival rate dillman said the bad news still didnt help 75 patients dr john glaspy director uclas joint oncology clinic said study proves benefits chemotherapy but noted even improved survival rates study good the big point reader youd better quit smoking quick glaspy said because big breakthroughs changing survival rates four months average aint much the threeyear study began 1984 examined 155 patients inoperable nonsmallcell lung cancer affects many 40000 americans dillman said it sponsored national cancer institute conducted cooperative group oncologists hoag massachusetts general hospital boston dartmouth college new hampshire uc san diego medical center mcgill university montreal university missouri columbia patients kind inoperable cancer given fiveweek course chemotherapy two doses drug cisplatin five doses vinblastine the duration short enough patients able tolerate side effects chemotherapy still benefit radiation treatment dillman said this followed six weeks daily treatments highdose radiation therapy concentrated chest area cancer visible dillman said major tumor shrinkage seen 44 patients got chemotherapy radiation contrasted 35 patients received radiation study said after one year treatment 55 underwent chemotherapy radiation therapy survived contrasted 40 among radiationonly group three years treatment 23 chemotherapyradiation group survived contrasted 11 radiationonly group the threeyear study followed three years tracking patients analyzing data dillman said at last count three chemotherapy radiation patients still alive four years treatment two massachusetts general hospital one mcgill university a confirming study sponsored national cancer institute way across country dillman said key finding chemotherapy especially earlier stages effective lung cancer many doctors realize most patients lung cancer diagnosed family practitioners general internists often initial care treatment decisions made physicians dillman said we know wait final stages lung cancer chemotherapy really late patients severe side effects wont tolerate therapy wont help